Month: November 2021

Kicking off any new year allows us to pause and reflect on the previous year’s actions and results. When you work within wound care, perhaps your first action this year was to review your schedule of patients to ensure they were provided the proper time to be seen, or review your staffing matrix to ensure you are you are meeting the needs of the scheduled patients, or dig into your supply cabinets to ensure inventory is abundant. Each action is vital to maintain your business and is interconnected to your unique process … read more

How reliable are our screening tools for peripheral arterial disease (PAD)? A recently published meta-analysis suggests that while our current diagnostic testing measures are promising, one should be wary of relying upon any one tool in isolation in patients with diabetes.

In their 2020 study in the Journal of Vascular Surgery, Normahani and coworkers reviewed and analyzed studies to evaluate the accuracy of bedside testing for PAD in patients with diabetes.1 In examining the diagnostic accuracy of the ankle-brachial pressure index (ABPI), the toe brachial pressure index (TBPI) and the tibial waveform assessment, these authors reviewed 11 studies (including a total of 1,543 limbs) … read more

In this podcast, Laura Swoboda, DNP, APNP, FNP-C, CWOCN-AP, shares expert knowledge on the human microbiome and its influences on the immune response, inflammation, and metabolism, which can impact wound healing … listen

Chronic wound care is challenging for the entire healthcare ecosystem, from clinicians to patients, and COVID-19 has only exacerbated those challenges. Patients are delaying primary care provider and wound clinician visits for ongoing guidance and therapy to reduce possible exposure to the virus. This is understandable, as many chronic wound patients are in the high-risk category if they become ill with COVID-19.1 They are also putting off elective surgeries, annual physicals, and basic preventive care, which can negatively affect long-term outcomes. A survey of wound care clinicians in March 2021 reported a decrease in patient visits from pre-pandemic numbers, and 57% of respondents stated that “wound severity has either increased or significantly increased since the start of the pandemic.”2 At the same time, the pandemic has accelerated patient-driven care and increased usage of interactive devices for care administered at home, rapidly increasing the use of telemedicine across demographics … read more

APO-2 (Aposec) is a secretome-based trial preparation derived from stressed peripheral blood mononuclear cells. APO-2 was shown to be safe and effective in a multinational Phase I study in patients with diabetic foot ulcers (non-healing foot ulcers). The Data Safety Monitoring Board has therefore recommended continuation into a Phase II clinical trial. This represents a major success for the wound healing preparation developed at MedUni Vienna … read more

But there is legislation moving through Congress that seeks funding to improve public awareness and early detection.

Vascular surgen Dr. Lee Kirksey of the Cleveland Clinic said there is no disease that ravages the body quite like diabetes. The complications can be serious: heart attacks, strokes, kidney failure and the most worrisome and drastic of all, limb loss.

“When I talk to diabetics, their greatest fear and they know that they can have a heart attack or stroke, their greatest fear is having to have an amputation,” said Dr. Kirksey.

According to Dr. Kirksey, as many as 25% of patients with diabetes at some point will develop a foot ulcer and if left untreated, that ulcer can lead to infection and amputation … read more

Venous leg ulcers (VLUs) are the most common causes of leg ulcers due to venous insufficiency. Most cases persist for more than 6 weeks, referred to as chronic VLUs. These chronic ulcers have been described as a manifestation of Klinefelter syndrome (KS). Platelet-rich fibrin (PRF) is a second-generation platelet concentrate, which contains growth factors required for chronic wound healing. The use of PRF in the management of VLUs in KS has not been reported, to the best of our knowledge. We report a case of chronic VLU associated with KS in a 41-year-old man treated with PRF. Dermatological examination showed a tender, shallow, irregular ulcer partly covered with hard, yellow necrotic tissue on the anterior side of the lower-left leg and hyperpigmented indurated skin on both lower legs. The diagnosis of venous ulcer was established based on clinical manifestation and supported by the result of Doppler ultrasound showed chronic venous insufficiency. Histopathological examination, which showed epidermal acanthosis … read more

A medical doctor says the proportion of diabetes cases that developed complications may have risen by roughly 15 to 20 per cent.
KUALA LUMPUR, Nov 25 — Late detection and interruptions to clinic visits for diabetic treatments during the Covid-19 pandemic have led to complications in some patients … Many had their appointments deferred as the government imposed a nationwide lockdown in March last year … “Because of the first movement control order (MCO 1.0), there is a higher chance for us to see patients who are coming in, not only with diabetic foot ulcers, but some may have rot their toes and limbs,” the doctor said … read more

Determining Wound Etiology:
Predominant pain pattern, ulcer location, ulcer appearance, type and amount of wound exudate, and vascular and sensorimotor assessment are some key factors used to determine the primary etiology of lower extremity ulcers.1

Etiology Guides Treatment:
Certain patients will have a clear presentation of wound etiology, whereas others may present with a mixed wound appearance. The certified wound specialist will complete a thorough history and physical assessment when determining wound etiology. From there, an individualized plan of care will be created, implemented, and continuously evaluated. For example … read more

Q: What resources do you use and/or recommend for physicians to educate themselves on health inequities, especially in the field of wound care?
A:
Babajide Ogunlana, DPM, FACFAS, encourages physician to learn first-hand by engaging in community outreach-type programs that seek to improve access to care.

“The field of wound care has a lot of cost implications that tend to tilt the services offered and/or available to the patient in the direction of who can afford it or whose insurance company … read more

KUWAIT: Dasman Diabetes Institute (DDI), a leading diabetes research Institute established by the Kuwait Foundation for the Advancement of Sciences, held recently its specialized three-day course on the ‘Prevention and Management of Diabetic Foot Complications’.

This program was held at the Institute and attended by healthcare professionals. Trainees learned to assess and treat the feet in people with diabetes using evidence-based assessment and treatment methods, aimed at reduction of diabetic foot ulceration and amputation. This program was organized and delivered by Kay Scarsbrook Khan, Chief Podiatrist and Dr Abdullah Al-Ajmi … read more

This descriptive cross-sectional study was conducted in a university hospital wound care unit in western Turkey with 134 patients. The data were collected via personal information form, Barthel Index for activities of daily living, visual analog scale, and Short Form-12 questionnaire. Descriptive statistics and Spearman correlation were used for data analysis … read more

OBJECTIVE: To investigate the prevalence of anxiety and depression among hospitalized patients with a chronic wound and explore the influence of demographic factors, disease characteristics, social support, and coping styles on their mental status … read more

A study published in the Advances in Skin & Wound Care Journal examined wound care information to help educate about care for the specific physiology of newborns.

A group of researchers aimed to help physicians differentiate the use of hydrocolloids, hydrogels, foam dressings, and barrier creams in the neonatal population and identify issues related to the use of solvents, alginates, collagen dressings, and negative pressure wound therapy (NPWT) in neonates, according to an article in the Advances in Skin & Wound Care journal.1

PubMed, Google Scholar, and other journals/textbooks were used to help collect data on wound healing in newborn patients. With this data, the authors of the study aimed to discuss what is already known about wound milieu in premature and full-term neonates, including the unique challenges pediatric clinicians face, the therapies that have proven effective, and the therapies … read more

A study investigated the clinical and economic burdens of wound care in the Tropics during a 5-year institutional review.

In an article published in the International Wound Journal, researchers evaluated the clinical and economic burden of wound care in the Tropics during a 5-year institutional population health review that occurred from 2013 to 2017.1

The 55,583 wounds included in the study were classified into different subtypes: neuro-ischaemic ulcers (NIUs), venous leg ulcers (VLUs), pressure injuries (PIs), and surgical site infections (SSIs). There were 41,461 patients admitted during that time with a 95.1% increase in wound episodes per 1000 inpatient admissions during this period (142 and 277 wound episodes per 1000 inpatient admissions in 2013 and 2017, respectively).

In 2017, the average amount of time a patient had to stay in the hospital for wound care were 17.7 … read more

Do you remember that cartoon from the 1960s (and later reproduced in the 1980s), The Jetsons? It was about a futuristic family that had all kinds of amazing robot helpers and automatic appliances. Rosie the Robot was the wonderbot that would whisk about the house, frantically preforming housekeeping duties, monitoring the security of the home, and generally making sure that everything was online and functioning. Do you ever feel like this as a clinician? Rushing about, multitasking, being pulled in what seems like a hundred different directions, all while expected to perform with “Rosie-like” perfect, machine-like efficiency. Wouldn’t it be wonderful to have Rosie’s artificial intelligence technology … read more

 

Related: Pressure Injuries and Disparities in Health Care: Important Terms to Know

In the last 2 years, hospitals and skilled nursing facilities have seen unprecedented surges in admissions attributed to the COVID-19 pandemic sweeping across the world. Just in the United States, we saw a high of 116,243 weekly hospital admissions in mid-January of 2021. This dropped to a low of 13, 424 in mid-June of 2021 and then bumped up again to 86,871 in August of 2021.1 With this fluctuation of numbers, along with staffing shortages and burnout, wound care professionals have seen significant overcrowding in many hospitals and facilities. Caregivers and clinicians are stretched thin. They are taking on more patients, who tend to be sicker and with more acute needs on a global scale. These patients tend to be at higher risk of developing a pressure injury … read more

The crystalline clarity with which smartphones can now capture images has been put to another innovative use: monitoring patients who’ve undergone emergency abdominal surgery for surgical-site infections (SSIs) and allowing physicians to diagnose them earlier in the postoperative period before they morph into a much bigger problem.

“Since the COVID-19 pandemic started, there have been big changes in how care after surgery is delivered,” Kenneth McLean, MBChB, University of Edinburgh, Scotland, observed in a statement.

“Patients and staff have become used to having remote consultations and we’ve shown we can effectively and safely monitor wounds … read more

Here’s a question for you: How long does it take for a pressure injury (PI) to form? Do you think it happens in 30 minutes? 2 hours? 8 hours? The answer is actually all of the above. The time it takes for a PI to develop depends on a number of different factors, which we will discuss here. This blog will describe how a PI forms, some signs that a PI is forming, and how to assess a patient’s skin for a PI. It will then look at some types of intervention and assessment that help in the prevention and treatment of a PI, as well as track its healing or declination … read more

When bacteria make their way into wounds, they literally threaten life and limb—unless they are detected as quickly as possible. A new sensor can nestle in bandages and alert a nearby smartphone when the bacterial population tips over into dangerous territory.

Healthy human skin is covered with bacteria such as Staphylococcus aureus and Escherichia coli, which are quick to colonize an open wound. To prevent the bacteria from spreading through the body, which can permanently injure or kill a person, the infected wound may need to be cleaned and treated with antibiotics or—in the most extreme situations—the affected limb may require amputation … read more

A nurse recently shared some of her experiences as a charge nurse in a skilled facility during the COVID-19 pandemic. She worked evenings (3-11:30 pm) at a local facility and was overwhelmed by the high number of patients she was responsible for. She typically worked on a 26-bed floor with just one nurse assistant for the shift. She later transferred to the night shift, where she was the only person on a 16-bed unit for the 8 hours. When asked how she was able to reposition patients as frequently as was recommended, the nurse said that she did “the best I could.” She is, unfortunately, not alone … read more

The FDA accepted a priority review of a supplemental new drug application for setmelanotide (Imcivree), a melanocortin-4 receptor agonist, for the treatment of Bardet-Biedl syndrome and Alström syndrome, Rhythm Pharmaceuticals announced. The FDA assigned a Prescription Drug User Fee Act (PDUFA) goal date of March 16, 2022 … After getting the green light from the FDA, Paracrine announced plans to initiate its pivotal ASCEND trial testing its Celution System for diabetic foot ulcers … read more

ProgenaCare Global, formerly Cell Constructs, has developed innovative products for wound healing that provide excellent outcomes for patients, while advancing the use of renewable materials. The company’s wound care technology, ProgenaMatrix™, incorporates human keratin as a major component of the highly effective and affordable wound therapy.

The all-natural robust human keratin protein option that constitutes this specialized biomaterial offers a completely unique solution to wound care clinicians. The human keratin technology in ProgenaMatrix is hydrated, non-cellular (not tissue-based), non-resorbing and supports the body’s own healing process. The bio-inspired design makes ProgenaMatrix the next generation of advanced wound therapy in the CMS skin substitute category … read more

---

Help support non-profit medical journalism. If you find WoundCareWeekly.com of value please consider a monthly donation to help cover expenses and keep this website going.
 

ATLANTA, November 17, 2021 / PRNewswire / – ProgenaCare Global, formerly Cell Constructs, has developed innovative wound healing products that deliver great patient outcomes while advancing the use of renewable materials. The company’s wound care technology, ProgenaMatrix™, contains human keratin as the main component of highly effective and inexpensive wound therapy.

The all-natural, rugged human keratin protein option that makes up this specialized biomaterial offers surgeons a completely unique solution. The human keratin technology in ProgenaMatrix is ​​hydrated, non-cellular (non-tissue-based), non-resorbing and supports the body’s own healing process. The bio-inspired design makes ProgenaMatrix the next generation of advanced wound therapy in the CMS skin replacement category.

Keratin technology has been in the published literature for over a century with applications in wound healing, drug delivery, tissue engineering, trauma and medical devices … read more

Her small toe was turning purple, and the pain was excruciating. Glory Paschal knew how fast this could spiral. She just had to look around her neighborhood in Watts to see how many residents were missing feet and legs.

She fought for a referral to a podiatrist, but by the time she saw one, it was too late.

On Feb. 10, 2011, doctors at Harbor-UCLA Medical Center had no option but to amputate her left leg below the knee.

This summer, the now 53-year-old Black grandmother was back in the hospital, this time with two infections particularly lethal for a diabetic: severe COVID-19 had her gasping for breath and gangrene was eating away at her remaining foot … read more

U.S. Pivotal Trial in Patients With Diabetic Foot Ulcers
Paracrine, Inc. announced today that the FDA has granted full approval of its Investigational Device Exemption (IDE) to conduct a new pivotal trial titled Adipose Derived Regenerative Cells (ADRCs) in the Treatment of Diabetic Foot Ulcers (DFUs): A Prospective, Double-blind, Multi-center, Randomized, Parallel-group Study – The “ASCEND Trial.”

The ASCEND Trial is a Pivotal Trial designed to provide a robust data set on the safety and efficacy of ADRCs in the treatment of patients with DFUs. The trial will include up to 291 patients at 25 clinical sites in the U.S. Trial results will be submitted in a Premarket Approval (PMA) application to the FDA to support regulatory approval.

Dr. Robert G. Frykberg, Co-Principal Investigator for The ASCEND Trial and past Foot Care Council Chair of the American Diabetes Association, stated: “Despite recent advancements in wound care and pharmacotherapy techniques, up to one quarter of patients with diabetes will develop diabetic foot ulcers – a leading cause of disability worldwide. The goal of this pivotal study is to compare the use of ADRCs against the current standard of care and determine if ADRCs can improve clinical outcomes in this challenging patient population.” … read more

Soft K-Cot® brush-curette is designed to be both minimally invasive and clinically effective for wound hygiene, debridement, and optional tissue sampling. The nitrile finger cot tip is coated with Kylon®, a patented medical fabric which dislodges and collects wound debris efficiently and effectively.

 

Histologics LLC’s primary objective is to advance a compassionate approach to debridement and wound sampling with devices using Kylon®, a medical fabric enabling frictional tissue cleaning, and debridement with optional specimen capture.

 

Benefits:

• Fabric disk on finger cot tip is designed for flat or curved wounds that are visible on the body surface
• Versatile use, Ergonomic, and minimally invasive design facilitates user tactile control for targeting and guiding the brushing, sweeping and rotational movements – modulating tactile pressure and method allows for light brushing away of debris versus pressure twisting motion curettage of the wound surface.
• Kylon® medical fabric hooks gently, yet substantially excavates the wound surface, dislodging debris and necrotic tissue, which can be easily wiped off the wound surface with gauze
• Designed for compassionate patient experience and compliance
• Promotes the efficiency of a debriding procedure
• Abundant tissue samples can be collected, stored and transported for laboratory analysis

Indications:
The Soft K-Cot® is indicated for patients with small to moderate sized (no larger than 6cmx6cm), non-fibrotic surfaces of wounds requiring cleansing or debridement in order to remove non-viable tissue and debris. Debridement may stimulate blood flow to encourage tissue regrowth. It is also indicated for scraping or debriding and then transporting tissue requiring histological analyses for further laboratory evaluation regarding infection or other pathology.

 

Contraindications:
Soft K-Cot® is contraindicated for use with patients with known bleeding disorders or those on anticoagulant therapy, patients with an acute wound infection or condition that is not amenable to debridement, patients with a known allergy to nylon or acrylic plastic, or patients who are pregnant or suspected to be pregnant when a wound biopsy would not be indicated.

 

Warnings and Precautions:
Federal law restricts this device to sale by or on the order of a physician or other licensed practitioner.

 

Storage Requirements:
Consult manufacturer on special storage requirements outside of normal room temperatures.

 

How Supplied/Sizing:
Box of 25 minimum order

 

Recommended Use:

• Burns
• Chronic Wounds
• Diabetic Foot
• Graft Bed Preparation
• Non/Minimally Exudating Wounds
• Palliative Wounds
• Pressure Ulcers
• Sloughy Wounds
• Surgical Wounds
• Venous Ulcers

 

Mode of Use/Application:
See manufacturer’s website for detailed instructions for use (IFU):
Instructions for use

 

Clinically Tested:
Latex-friendly

 

Product features:

• Single Use
• Disposable
• Instrument
• Sterile
• Variety of sizes

 

Other features:

• Educational Material Available
• Free Samples/Trials Available
• Published Clinical Study Available

 

Free Sample Kit Available on Request to:
support@histologicswc.com

 

Histologics LLC, 4095 E. LaPalma Ave, St N, Anaheim, CA 92807, (888) 235-2275
www.histologicswc.com
support@histologicswc.com

My colleagues, Barbara Delmore PhD, RN, CWCN, MAPWCA and Jill Cox PhD, RN, APN-c, CWOCN, and I have written a paper,1 available electronically ahead of print, that reviews the skin failure concept, defines related controversies, and proposes a model for its pathogenesis. Like all other organs, skin can fail; however, experts continue to grapple with definitions, causative factors, and manifestations. By defining contributing factors that apply to other organ systems, providers establish skin failure as an entity and thus are able to recognize and address it in practice. This also enables providers to assist regulators by incorporating these pathophysiologic factors into modification of quality measurement criteria. Unifying the concept across the health care continuum … read more

Global Business Leaders magazine features Kent Imaging: Setting A New Global Standard in Advanced Tissue Assessment.

CALGARY, ALBERTA, CANADA, November 16, 2021 /EINPresswire.com/ — Kent Imaging Inc., a leading innovator in oxygenation imaging is pleased to report that the company has been named #15 on the list of “The 20 Most Promising Businesses to Watch in 2021” by Global Business Leaders magazine.

Kent Imaging’s flagship product is SnapshotNIR, a handheld and lightweight point-of-care device that can capture tissue oxygenation in superficial tissue with a single click of its camera-like structure. Using multiple wavelengths of near-infrared (NIR) light, SnapshotNIR non-invasively measures relative amounts of oxygenated and deoxygenated hemoglobin in the microcirculation of tissue where oxygen exchange is happening.

With the innovative SnapshotNIR device, Kent is focused on delivering improved usability to enhance workflow integration … read more

Although silver is highly effective at killing bacteria, it can also be toxic to humans in large amounts. That’s where a new wound dressing is intended to come in, as it only releases its silver payload when infections are present.

Currently being developed at the University of South Australia, the dressing is intended mainly for use on children with burn injuries, as they are particularly at risk of serious infections and sepsis. It’s made up of a topically applied hydrogel that contains silver nanoparticles along with proprietary ingredients which are sensitive to changes in pH and temperature … read more

EATONTOWN, NJ / ACCESSWIRE / November 16, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a clinical stage biotechnology company, global licensor and a pioneer in autologous cellular processing and therapies announced today that it has completed the development of a new standardized wound healing protocol utilizing its tissue based technologies with Advanced Regenerative Associates (Tinton Falls, NJ). The Company’s wound healing technologies rely on exemptions from FDA clinical study and approval for the use of human tissue and cell products (PHS 361 and 21CFR1271.10) and is incorporated into the current standards of care protocols currently in use. The new protocol is focusing on realigning the microenvironment of the treatment area to achieve greater healing support during the treatment period utilizing current standard of care protocols. The initial rollout is fashioned as a study to collect additional information about the wound environment and healing progress. The Company intends to obtain informed consent from each participant for the collection, analysis and potential publication of the assessment data as required under current regulations … read more

BOCA RATON, Fla., Nov. 14, 2021 /PRNewswire/ — CūtisCare, a leading provider of wound care management services to hospitals and physicians, is continuing our fight this month to raise awareness regarding diabetes and the available treatment options to help save limbs and lives. According to the CDC, diabetes currently adversely impacts the lives of approximately 34 million Americans, and that number is continuing to increase each year. About 25% of people with diabetes will develop foot ulcers, and 1% end up with an amputation in their lifetime. However, as many as 85% of potential amputations can be avoided when advanced modalities, such as hyperbaric oxygen therapy, or HBOT, are added to a treatment plan.

There is good news on the horizon though. Many of these amputations are preventable. HBOT is one therapy that is showing great promise. Louis Pilati MD, CutisCare’s Medical Advisory Board Member, expounds on the manifold benefits of HBOT for patients with Wagner Grade 3 or higher … read more

Safe and effective – wound healing preparation reaches clinical phase II: APO-2 (Aposec) is a secretome-based trial preparation derived from stressed peripheral blood mononuclear cells.

APO-2 was shown to be safe and effective in a multinational Phase I study in patients with diabetic foot ulcers (non-healing foot ulcers). The Data Safety Monitoring Board has therefore recommended continuation into a Phase II clinical trial. This represents a major success for the wound healing preparation developed at MedUni Vienna. APO-2 contains the secretome … read more

I have on several occasions had the unpleasant duty of telling family, friends and clients about a medical condition that they may be challenged with; heart disease, stroke, HIV, COVID-19, cancer etc. but none of them seem to have the same impact as DIABETES. Many people who have never seen the inside of a church building will break out into uncontrollable “tongues” that will amaze even the Apostles at Pentecost. That is how much diabetes is feared and it can cause havoc if not managed properly.

Diabetes on its own will not kill even if it wipes your bank account dry BUT the organ complications that come with poor management or no management is the killer … read more

Delayed wound healing and the resulting impact to the cost of care impacts both patients and facilities across the healthcare continuum. When it comes to wound care, no one is comfortable choosing a service provider with only a basic understanding of the subject. Thus, a product specialist with a historical legacy of providing effective products will invariably gain market traction due to its reliability. Founded in 1995, Hymed has been a renowned name in the healthcare industry for over two decades, offering safe and efficacious, natural wound care products. The company is the developer of innovative wound care products that utilize collagen (the chief structural protein of the body), hyaluronic acid (HA) and glycosaminogly can chemistry for human and animal use. In addition to wound care, these products find varied applications in joint/tissue support, surgery, eye care, dental, and dermatology, and the cosmetic industry … read more

Africa is set to see diabetes cases more than double to 55 million by 2045, the biggest increase across the globe, the World Health Organization (WHO) warned Thursday.

“The COVID-19 pandemic will eventually subside, but Africa is projected in the coming years to experience the highest increase in diabetes globally,” said Dr. Matshidiso Moeti, WHO Regional Director for Africa.

Twenty-four million people are living with diabetes today in Africa, which is also the region with the “highest number of people who do not know their diagnosis,” the WHO statement said … read more

“Foot selfies” may be a simple solution to keeping tabs on patients at high risk for diabetic foot complications.

Patients with or at risk of foot ulcers are told to check their feet regularly at home, but doing so can be difficult for those who aren’t flexible or who have vision problems. Those who live alone may not be able to ask someone else to check their feet for them. Some use hand mirrors, but those can be difficult to manipulate and don’t offer feedback … read more

A new foot ulcer formulation developed by scientists at the University of South Australia could be used to kill the COVID-19 virus, according to new research.

In a study published in the journal Applied Physics Letters, the team looked at the treatment of antimicrobial-resistant bacterial infections, experimenting to find an effective non-antibiotic antimicrobial strategy to combat the infections in diabetic foot ulcers.

The authors found that enhancing cold plasma ionized gas with peracetic acid was “highly effective” at eradicating common wound pathogenic bacteria and at inactivating SARS-Cov-2 … read more

Freudenberg Performance Materials will showcase its multi-layer material compositions of hydrophilic PU foams and hydroactive nonwovens for sustainable woundcare at Compamed in Düsseldorf from November 15-18 2021.

The Eco-Check label endorses particularly sustainable solutions for the design of wound plasters which use bio-based raw materials, allowing biodegradation in an industrial composting setting after the product has been used.

M 1701 for traditional woundcare plasters comprises 100% polylactid acid derived from natural resources and offers good woundcare characteristics, while M 1714 has superior absorption for more challenging wounds and consists of a mix of bio-based fibres. With a smooth wound contact layer, M 1714 has already been evaluated for industrial compostability and conforms with the ISO 13432 standard … read more

BACTERIAL BURDEN IN WOUNDS

High bacterial load contributes to chronicity of wounds and is diagnosed based on assessment of clinical signs and symptoms (CSS) of infection, but these characteristics are poor predictors of bacterial burden. Point-of-care fluorescence imaging (FL) can improve identification of wounds with high bacterial burden (>10⁴ CFU/g). FL detects bacteria, whether planktonic or in biofilm, but does not distinguish between the two. In this study, diagnostic accuracy of FL was compared to CSS during routine wound assessment … read more

PIEZO1, an ion channel mechanosensor found within cells, has been revealed to play a key role in regulating the speed of skin wound healing by researchers at the University of California, Irvine (UCI).

Published today in eLife, the study (“Spatiotemporal dynamics of PIEZO1 localization controls keratinocyte migration during wound healing”) found that in mice lacking the ion channel protein PIEZO1 in keratinocytes, skin wounds heal faster than in mice with increased PIEZO1 function in keratinocytes … read more

The Wound Care unit at Decatur County Memorial Hospital has been selected to participate in a new study on the uses of hyperbaric oxygen treatment in partnership with the Indiana Department of Health and the Department of Veterans Affairs.

The HBOT Pilot Program will study the effect that hyperbaric chamber treatments can have on PTSD and traumatic brain injuries in veterans.

The VA seeks to improve the lives and health of veterans, and they have seen significant anecdotal evidence of the symptoms of PTSD decreasing and traumatic brain injuries improving during hyperbaric therapy … read more

an ion channel mechanosensor found within cells, has been revealed to play a key role in regulating the speed of skin wound healing by researchers at the University of California, Irvine (UCI).

Published today in eLife, the study, titled, “Spatiotemporal dynamics of PIEZO1 localization controls keratinocyte migration during wound healing,” found that in mice lacking the ion channel protein PIEZO1 in keratinocytes, skin wounds heal faster than in mice with increased PIEZO1 function in keratinocytes … read more

with Dyamed Biotech for New Territories and Products in Southeast Asia
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions and disinfectant use, and its long-time partner, Dyamed Biotech Pte Ltd., announce a renewed and expanded long-term partnership for Singapore, Malaysia, Indonesia and Thailand for multiple indications using Sonoma’s patented Microcyn® Technology.

Dyamed Biotech Pte Ltd., one of Sonoma’s first international partners, successfully commercializes Dermacyn® Wound Care, Dermacyn® Scarless for Scar Reduction, and Dermacyn® Ezyma Spray for itch relief associated with atopic dermatitis. Dyamed expects to launch Ocucyn® Eye Care and Oracyn® Oral Care in 2022. The Dermacyn® line of products are widely used at many hospitals throughout Singapore and Malaysia … read more

Healing of Chronic Diabetic Foot Ulcers (OTONAL Trial)
Natrox™ topical oxygen therapy (TOT) (Inotec AMD Ltd, Hertfordshire, UK) employs a small battery-powered “oxygen generator” to concentrate atmospheric oxygen and feeds pure, moist, oxygen through a fine, soft tube to a dressing-like “oxygen distribution system”, which is placed over the wound and is held in place by a conventional dressing. The aim was to determine the effectiveness of Natrox™ for non-healing diabetic foot ulcers (DFU) over a 3-month period.Longitudinal, single-arm, open prospective registry study using 12 weeks of TOT using a 4 week run-in period. 20 patients recruited to OTONAL had chronic DFU greater than 3 months duration or minor amputation sites with less than 50% healing in 4 weeks.There were 13 (65%) males and the mean age was 65.7 (±11.6) years. The mean glycated haemoglobin (HbA1c) was 6.9 (±1.3) mmol mol-1 and mean wound duration before TOT was 114 (±79.1) days. 18/20 (90.0%) patients had concomitant lower limb revascularization angioplasty for chronic limb threatening ischaemia. The mean size … read more

November is Diabetes Awareness Month, a time to bring attention to this fast-growing, life-threatening epidemic. Currently more than 34 million Americans have diabetes and this number is expected to increase to 54.9 million by 2030. Increases have been attributed to a rise in obesity rates and an aging population, but new research shows that younger people are being diagnosed with the disease. From 2001 to 2017, the number of people under age 20 living with diabetes increased by 45 percent, and the number living with type 2 diabetes grew by 95 percent. This troubling development is expected to further challenge the healthcare system in the coming decades … read more

Skin wounds from ischemia-reperfusion injuries — tissue damage caused by blood returning to tissues after a period of oxygen deprivation — may not heal appropriately in some patients, owing to elusive underlying immunological mechanisms. Scientists from Japan have now succeeded in proposing a means to solve this medical conundrum by understanding the role of interleukin-36 receptor antagonists as they act to inhibit the effects of interleukin-36 cytokines, which could help identify new therapeutic targets for wound healing … read more

Patients with peripheral arterial disease (PAD) are at very high risk of cardiovascular events, but risk factor management is usually suboptimal. This Joint Task Force from the European Atherosclerosis Society and the European Society of Vascular Medicine has updated evidence on the management on dyslipidaemia and thrombotic factors in patients with PAD. Guidelines recommend a low-density lipoprotein cholesterol (LDLC) goal of more than 50% reduction from baseline and <1.4 mmol/L (<55 mg/dL) in PAD patients. As demonstrated by randomized controlled trials, lowering LDL-C not only reduces cardiovascular events but also major adverse limb events (MALE), including amputations, of the order of 25%. Addition of ezetimibe or a PCSK9 inhibitor further decreases the risk of cardiovascular events, and PCSK9 inhibition has also been associated with reduction in the risk of MALE by up to 40%. Furthermore, statin- based treatment improved walking … read more

Joseph Borg, a lecturer and researcher in Applied Biomedical Science at the University of Malta’s Faculty of Health Sciences, will deliver a talk and presentation on Wednesday, November 10 at 7pm at Spazju Kreattiv, Valletta, regarding an experiment on diabetes he is conducting at the International Space Station (ISS) as part of Project Maleth.

Prof. Borg’s experiment is the first Maltese presence at the ISS, launching the nation into a new era of involvement in space … read more

Isolates Among Post-Operative Patients in Harari Region Public Hospitals, Harar, Eastern Ethiopia
Surgical site infections (SSIs) are infections that occur one month after a surgical operation or one year after implant surgery and a surgical procedure, either at the injury site or near the injury site. Surgical site infections are still a major global problem, especially in developing countries, where they cause increased morbidity and mortality. There is a dearth of information regarding SSIs in the eastern Ethiopia, particularly in this study area … read more

Researchers at the University of Bath in the UK, along with outside collaborators, have developed a simple color change test that rapidly indicates whether a wound is infected with harmful bacteria. The test works by detecting virulence factors released by the bacteria, which prompt a simple color change in a solution. The test could help clinicians to determine whether to prescribe antibiotics, and may help to avoid unnecessary prescribing. As the test can be administered at the point of care, and does not require expensive and time-consuming laboratory analysis, it may be very useful in low-resource or remote regions … read more

Industry researchers have used machine learning to predict healing times for wounds based in part on patient data stored in electronic health records.

The team suggests its model can help clinicians make optimal decisions for treating slow-to-heal abrasions, lacerations and so on by knowing which new and preexisting patient traits are most likely to influence outcomes.

The study was conducted by staff members of Net Health, a supplier of software and analytics services, and is current in Advances in Wound Care.

The team trained AI prediction models on data from more than 1.2 million wounds … read more

Herzliya-based MedCu’s product have already been approved by the US FDA.
An innovative Israeli-made wound dressing has been found to drastically stimulate the healing of diabetic wounds, a new study by physicians at the Rambam Health Care Campus in Haifa has found.
Copper Oxide Impregnated Wound Dressings, developed by Herzliya-based MedCu Technologies, have already received clearance by the major international regulatory bodies – including the United States’ FDA – for use in acute and chronic wounds.
“What is special about our dressing is that it contains particles of copper oxide,” said Dr. Gadi Borkow … read more

This month we celebrate World Diabetes Day on November 14,1 which is the birthday of Dr Frederick G. Banting, one of four key collaborators in the discovery of insulin. He pursued the idea that an important element in the pancreas could help save the lives of persons with type 1 diabetes: insulin. It took the other members his team—collaborators at of the University of Toronto— to isolate insulin from the pancreas and formulate it into a lifesaving clinical reality. All of this happened 100 years ago this November, when the researchers demonstrated that insulin extract reduced blood sugar in laboratory animals.1 Because they felt so strongly that this medical breakthrough had to be available to all, they sold the patent for 100 cents ($1) so insulin could be affordable for everyone who needed … read more

CMS CY 2021 hospital outpatient and physician fee schedule proposed rules
The Center for Medicare and Medicaid Services have released for comment its proposed CY 2021 updates to the Hospital Outpatient Prospective Payment System and Physician Fee Schedule. Below, verbatim, are several provisions the Alliance of Wound Care Stakeholders has identified as particularly impacting wound care clinicians, which the Alliance will be tracking and preparing comment on … read more